Brief: I-Mab Announces Positive Outcome In Arbitration Relating To Agreements With Tracon
April 25 (Reuters) - I-Mab IMAB.O :
* ANNOUNCES POSITIVE OUTCOME IN ARBITRATION RELATING TO
AGREEMENTS
WITH TRACON
* BASED ON ARBITRATION AWARD, I-MAB WILL BEAR A PORTION OF
TRACON'S LEGAL FEES AND COSTS, TOTALING APPROXIMATELY $13.5
MILLION.
Source text for Eikon: ID:nPn4DzpXNa
Further company coverage: IMAB.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on NovaBridge Biosciences
See all newsBrief: Visara Secures Exclusive Option For Potential Acquisition Of Yol104-2 For Ocular Surface Squamous Neoplasia
Brief: Visara Expands Ophthalmology Pipeline With Exclusive License For Investigational Nerve Growth Factor Therapy For Neurotrophic Keratitis
Brief: Wuhan Hiteck Biological Pharma Grants Visara Exclusive Rights To HT006.2.2 Outside Greater China
Brief: Novabridge Biosciences Announces Expanded Givastomig Safety And Efficacy Data
NovaBridge Biosciences expected to post a loss of 13 cents a share - Earnings Preview